19,400 Shares in Bowhead Specialty Holdings Inc. $BOW Acquired by Cynosure Group LLC

Cynosure Group LLC acquired a new stake in Bowhead Specialty Holdings Inc. (NYSE:BOWFree Report) during the second quarter, Holdings Channel.com reports. The fund acquired 19,400 shares of the company’s stock, valued at approximately $728,000.

Several other institutional investors have also added to or reduced their stakes in the company. Bank of New York Mellon Corp lifted its stake in Bowhead Specialty by 34.5% during the first quarter. Bank of New York Mellon Corp now owns 39,750 shares of the company’s stock worth $1,616,000 after purchasing an additional 10,200 shares during the last quarter. New York State Common Retirement Fund raised its holdings in shares of Bowhead Specialty by 238.9% during the 1st quarter. New York State Common Retirement Fund now owns 6,100 shares of the company’s stock worth $248,000 after buying an additional 4,300 shares in the last quarter. Knights of Columbus Asset Advisors LLC bought a new stake in shares of Bowhead Specialty during the 1st quarter worth $1,386,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Bowhead Specialty by 17.5% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,400 shares of the company’s stock valued at $301,000 after buying an additional 1,100 shares in the last quarter. Finally, Nemes Rush Group LLC bought a new position in Bowhead Specialty in the first quarter valued at about $61,000.

Analyst Upgrades and Downgrades

BOW has been the subject of a number of research reports. JMP Securities dropped their target price on shares of Bowhead Specialty from $43.00 to $40.00 and set a “market outperform” rating for the company in a report on Tuesday, October 14th. Piper Sandler dropped their price objective on shares of Bowhead Specialty from $38.00 to $33.00 and set an “overweight” rating for the company in a research note on Thursday, October 2nd. Zacks Research raised shares of Bowhead Specialty from a “strong sell” rating to a “hold” rating in a research note on Friday, August 15th. Keefe, Bruyette & Woods lowered their price target on shares of Bowhead Specialty from $45.00 to $42.00 and set an “outperform” rating for the company in a report on Tuesday, August 12th. Finally, Deutsche Bank Aktiengesellschaft began coverage on Bowhead Specialty in a report on Friday, August 8th. They set a “buy” rating on the stock. Four investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $35.40.

View Our Latest Stock Report on Bowhead Specialty

Bowhead Specialty Price Performance

BOW opened at $27.44 on Friday. Bowhead Specialty Holdings Inc. has a fifty-two week low of $23.50 and a fifty-two week high of $42.29. The company’s 50 day moving average price is $26.22 and its two-hundred day moving average price is $31.47. The firm has a market capitalization of $899.55 million, a price-to-earnings ratio of 17.59 and a beta of -0.93.

Bowhead Specialty (NYSE:BOWGet Free Report) last issued its quarterly earnings results on Monday, August 26th. The company reported $0.27 EPS for the quarter. The company had revenue of $65.45 million for the quarter. Bowhead Specialty had a net margin of 10.12% and a return on equity of 13.53%. As a group, equities research analysts predict that Bowhead Specialty Holdings Inc. will post 1.36 EPS for the current year.

About Bowhead Specialty

(Free Report)

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.

Recommended Stories

Want to see what other hedge funds are holding BOW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bowhead Specialty Holdings Inc. (NYSE:BOWFree Report).

Institutional Ownership by Quarter for Bowhead Specialty (NYSE:BOW)

Receive News & Ratings for Bowhead Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bowhead Specialty and related companies with MarketBeat.com's FREE daily email newsletter.